Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Clinical and Experimental Rheumatology|June 24, 2022
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia RegistryFabiola Atzeni, Alessandra Alciati, Laura Bazzichi, et al.
Clinical Reviews in Allergy & Immunology|January 29, 2022
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological AssociationsMicaela Fredi, Ilaria Cavazzana, Angela Ceribelli, et al.
Autoimmunity Reviews|February 2, 2017
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective studyElena Bartoloni, Miguel A Gonzalez-Gay, Carlo Scirè, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Rheumatology (Oxford, England)|August 15, 2020
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patientsFausto Salaffi, Marco Di Carlo, Laura Bazzichi, et al.
Clinical and Experimental Rheumatology|August 30, 2019
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patientsSoledad Retamozo, Nihan Acar-Denizli, Astrid Rasmussen, et al.
Rheumatology (Oxford, England)|April 6, 2022
Characterization and outcomes of 414 patients with primary SS who developed haematological malignanciesGabriela Hernández-Molina, Belchin Kostov, Pilar Brito-Zerón, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
Autoimmunity Reviews|December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' ConsensusRoberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Pageof 20